ATORVASTATIN CALCIUM, FILM COATED

ATORVASTATIN CALCIUM, FILM COATED was reported 71722 times

ATORVASTATIN CALCIUM, FILM COATED is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 164 0.5413
1 IMMUNE-MEDIATED NECROTISING MYOPATHY 136 0.2514
2 TYPE IIA HYPERLIPIDAEMIA 48 0.2051
3 AMAUROSIS FUGAX 157 0.1458
4 IMMUNE-MEDIATED MYOSITIS 342 0.1240
5 AUTOIMMUNE MYOSITIS 58 0.1229
6 NECROTISING MYOSITIS 94 0.1084
7 ALVEOLAR OSTEITIS 43 0.1017
8 FEMALE GENITAL TRACT FISTULA 172 0.1006
9 URINARY TRACT DISCOMFORT 46 0.0998
10 CATARRH 90 0.0996
11 STEROID DEPENDENCE 81 0.0923
12 PERIORBITAL PAIN 61 0.0720
13 RADICULOPATHY 178 0.0675
14 CHRONIC SINUSITIS 239 0.0636
15 MACULAR DEGENERATION 721 0.0603
16 PROCTITIS 168 0.0599
17 EYELID PAIN 108 0.0531
18 BURNS SECOND DEGREE 91 0.0518
19 MYOPATHY 418 0.0483
20 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 44 0.0475
21 ANIMAL SCRATCH 46 0.0473
22 BLOOD PRESSURE SYSTOLIC ABNORMAL 114 0.0461
23 INFUSION SITE DISCHARGE 76 0.0433
24 BLOOD PRESSURE DIASTOLIC ABNORMAL 106 0.0416
25 POLYMYOSITIS 70 0.0395
26 INFUSION SITE HAEMORRHAGE 124 0.0377
27 DEVICE INFUSION ISSUE 84 0.0338
28 URINARY TRACT DISORDER 151 0.0335
29 INFUSION SITE IRRITATION 43 0.0335
30 SEASONAL ALLERGY 445 0.0314
31 ALCOHOL POISONING 83 0.0310
32 HAEMORRHAGIC STROKE 238 0.0304
33 BRONCHIECTASIS 204 0.0302
34 TYPE 2 DIABETES MELLITUS 1019 0.0302
35 INFUSION SITE INFECTION 69 0.0297
36 HYPOPNOEA 103 0.0296
37 RALES 164 0.0282
38 OXYGEN CONSUMPTION INCREASED 65 0.0272
39 NASAL OBSTRUCTION 51 0.0272
40 OCULAR DISCOMFORT 301 0.0268
41 SINUS PAIN 62 0.0266
42 INFUSION SITE ERYTHEMA 222 0.0263
43 TUNNEL VISION 49 0.0261
44 POLYMYALGIA RHEUMATICA 83 0.0261
45 INFUSION SITE PRURITUS 80 0.0253
46 HIGH DENSITY LIPOPROTEIN DECREASED 84 0.0252
47 INFUSION SITE PAIN 316 0.0245
48 INFUSION SITE BRUISING 51 0.0236
49 CORONARY ARTERY STENOSIS 114 0.0226
50 INFUSION SITE SWELLING 141 0.0224
51 ESSENTIAL HYPERTENSION 41 0.0224
52 RHABDOMYOLYSIS 932 0.0223
53 BLOOD CHOLESTEROL DECREASED 41 0.0220
54 HYPERVOLAEMIA 106 0.0214
55 DYSPNOEA AT REST 62 0.0214
56 CYTOLYTIC HEPATITIS 69 0.0208
57 EAR CONGESTION 56 0.0206
58 MUSCLE RUPTURE 79 0.0203
59 THROAT CLEARING 74 0.0197
60 BLOOD PRESSURE SYSTOLIC INCREASED 382 0.0196
61 HAEMOGLOBIN INCREASED 87 0.0191
62 PARANASAL SINUS DISCOMFORT 72 0.0190
63 EYE PAIN 1071 0.0190
64 CARDIAC MURMUR 164 0.0189
65 AUTOIMMUNE HEPATITIS 130 0.0187
66 BLADDER PAIN 59 0.0186
67 DERMATOMYOSITIS 47 0.0185
68 BLOOD PRESSURE DIASTOLIC DECREASED 136 0.0184
69 BLOOD CREATINE PHOSPHOKINASE INCREASED 515 0.0179
70 OBSTRUCTIVE AIRWAYS DISORDER 198 0.0178
71 ORAL CANDIDIASIS 233 0.0177
72 PARAESTHESIA ORAL 255 0.0177
73 GINGIVAL PAIN 137 0.0172
74 CARDIAC FAILURE CHRONIC 73 0.0171
75 DYSPNOEA EXERTIONAL 632 0.0168
76 VAGINAL DISCHARGE 169 0.0167
77 MYOSITIS 146 0.0163
78 PHOTOPHOBIA 304 0.0161
79 PULMONARY PAIN 47 0.0161
80 WOUND SECRETION 63 0.0161
81 OXYGEN SATURATION ABNORMAL 45 0.0158
82 BLOOD IRON DECREASED 186 0.0157
83 DRUG TOLERANCE DECREASED 44 0.0157
84 NASAL POLYPS 77 0.0156
85 HEPATITIS CHOLESTATIC 94 0.0156
86 GENERALISED OEDEMA 192 0.0155
87 WOUND COMPLICATION 53 0.0154
88 HEAD DISCOMFORT 270 0.0152
89 RHINITIS 122 0.0151
90 ANGINA UNSTABLE 98 0.0151
91 MYALGIA 2559 0.0150
92 INFUSION SITE REACTION 44 0.0147
93 BODY TEMPERATURE DECREASED 145 0.0147
94 BLOOD CHOLESTEROL ABNORMAL 68 0.0147
95 MULTIPLE ALLERGIES 115 0.0147
96 DIZZINESS POSTURAL 142 0.0146
97 PAROSMIA 110 0.0146
98 SKIN LACERATION 157 0.0144
99 OXYGEN SATURATION DECREASED 803 0.0143
100 DYSLIPIDAEMIA 72 0.0142
101 FOREIGN BODY SENSATION IN EYES 88 0.0138
102 MUSCLE DISORDER 111 0.0137
103 DIASTOLIC DYSFUNCTION 42 0.0136
104 VENTRICULAR HYPOKINESIA 43 0.0134
105 POLYP 87 0.0133
106 PRODUCTIVE COUGH 633 0.0132
107 BLOOD POTASSIUM INCREASED 215 0.0132
108 FREQUENT BOWEL MOVEMENTS 357 0.0132
109 RESPIRATION ABNORMAL 91 0.0132
110 LOW DENSITY LIPOPROTEIN INCREASED 102 0.0132
111 ARTERIAL OCCLUSIVE DISEASE 103 0.0131
112 ANGINA PECTORIS 373 0.0130
113 BREATH SOUNDS ABNORMAL 64 0.0130
114 BUNDLE BRANCH BLOCK LEFT 55 0.0130
115 NEPHROGENIC ANAEMIA 60 0.0129
116 ATRIOVENTRICULAR BLOCK FIRST DEGREE 56 0.0129
117 RED CELL DISTRIBUTION WIDTH INCREASED 53 0.0127
118 BLOOD PRESSURE SYSTOLIC DECREASED 58 0.0127
119 LARGE INTESTINE POLYP 88 0.0127
120 BLOOD CREATINE INCREASED 56 0.0126
121 MITRAL VALVE INCOMPETENCE 142 0.0125
122 GLOMERULAR FILTRATION RATE DECREASED 152 0.0124
123 AORTIC STENOSIS 43 0.0123
124 EXERCISE TOLERANCE DECREASED 71 0.0123
125 SKIN WEEPING 44 0.0123
126 CHOKING SENSATION 68 0.0123
127 ACUTE CORONARY SYNDROME 102 0.0123
128 ATRIAL FLUTTER 98 0.0123
129 RESPIRATORY TRACT CONGESTION 194 0.0122
130 DEPRESSIVE SYMPTOM 43 0.0122
131 HAEMATEMESIS 309 0.0122
132 ARTERIOSCLEROSIS CORONARY ARTERY 80 0.0121
133 BLOOD MAGNESIUM DECREASED 104 0.0120
134 HYPOMAGNESAEMIA 167 0.0120
135 FINGER DEFORMITY 58 0.0120
136 DIVERTICULUM INTESTINAL 52 0.0119
137 INCORRECT DOSAGE ADMINISTERED 58 0.0118
138 ATRIOVENTRICULAR BLOCK COMPLETE 79 0.0118
139 LEFT VENTRICULAR HYPERTROPHY 50 0.0117
140 BLOOD PRESSURE FLUCTUATION 280 0.0117
141 SINUS DISORDER 227 0.0115
142 PROSTATOMEGALY 45 0.0114
143 RECTAL HAEMORRHAGE 492 0.0114
144 AORTIC VALVE INCOMPETENCE 48 0.0113
145 HAEMODIALYSIS 94 0.0112
146 HEART RATE DECREASED 393 0.0112
147 PRESYNCOPE 272 0.0112
148 MUSCLE ATROPHY 140 0.0110
149 BLOOD PRESSURE DIASTOLIC INCREASED 51 0.0110
150 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 45 0.0110
151 URINE ABNORMALITY 50 0.0110
152 LOSS OF CONTROL OF LEGS 41 0.0108
153 CORONARY ARTERY OCCLUSION 148 0.0108
154 DIABETIC NEUROPATHY 53 0.0107
155 SECRETION DISCHARGE 134 0.0107
156 ALTERED STATE OF CONSCIOUSNESS 230 0.0106
157 OVERWEIGHT 57 0.0106
158 TROPONIN INCREASED 80 0.0105
159 GLUCOSE TOLERANCE IMPAIRED 62 0.0105
160 HYPERURICAEMIA 43 0.0105
161 INITIAL INSOMNIA 107 0.0104
162 HYPOVOLAEMIA 61 0.0104
163 LIMB INJURY 281 0.0103
164 HAEMATURIA 353 0.0103
165 BLOOD UREA INCREASED 172 0.0103
166 APPETITE DISORDER 68 0.0102
167 SPUTUM DISCOLOURED 97 0.0102
168 FULL BLOOD COUNT ABNORMAL 108 0.0102
169 DRUG INTERACTION 1619 0.0102
170 RENAL CYST 81 0.0102
171 DERMATITIS CONTACT 116 0.0102
172 WALKING AID USER 67 0.0102
173 PROCEDURAL PAIN 281 0.0101
174 DIPLOPIA 261 0.0100
175 COUGH 2812 0.0100
176 HOSPICE CARE 98 0.0099
177 MUSCLE FATIGUE 42 0.0099
178 THROAT IRRITATION 444 0.0099
179 GASTRITIS EROSIVE 46 0.0099
180 SKIN HAEMORRHAGE 146 0.0098
181 BLOOD ALBUMIN DECREASED 78 0.0098
182 RENAL FAILURE ACUTE 414 0.0097
183 MYOCARDIAL ISCHAEMIA 111 0.0097
184 UPPER-AIRWAY COUGH SYNDROME 80 0.0097
185 HORDEOLUM 42 0.0097
186 TRICUSPID VALVE INCOMPETENCE 77 0.0097
187 TINNITUS 443 0.0096
188 HEPATIC ENZYME ABNORMAL 48 0.0096
189 CARDIAC FAILURE ACUTE 64 0.0096
190 MIDDLE INSOMNIA 179 0.0096
191 ACUTE MYOCARDIAL INFARCTION 281 0.0095
192 PERIPHERAL VASCULAR DISORDER 49 0.0095
193 UPPER GASTROINTESTINAL HAEMORRHAGE 160 0.0095
194 RHINORRHOEA 614 0.0095
195 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 161 0.0095
196 SINUS CONGESTION 128 0.0095
197 RESPIRATORY RATE INCREASED 84 0.0095
198 ARTERIOSCLEROSIS 89 0.0094
199 RESPIRATORY TRACT INFECTION 245 0.0094
200 BLOOD URINE PRESENT 177 0.0093
201 SKIN ABRASION 44 0.0093
202 TUBULOINTERSTITIAL NEPHRITIS 174 0.0093
203 FULL BLOOD COUNT DECREASED 187 0.0093
204 WEIGHT FLUCTUATION 97 0.0093
205 BLOOD CHOLESTEROL INCREASED 431 0.0092
206 PROTEIN URINE PRESENT 46 0.0092
207 GAMMA-GLUTAMYLTRANSFERASE INCREASED 204 0.0092
208 PERIORBITAL SWELLING 52 0.0092
209 GOUT 165 0.0092
210 HAEMATOCHEZIA 503 0.0091
211 HYPERKALAEMIA 319 0.0091
212 INSURANCE ISSUE 139 0.0091
213 HEPATIC STEATOSIS 169 0.0091
214 EJECTION FRACTION DECREASED 141 0.0091
215 PRODUCT DISTRIBUTION ISSUE 84 0.0090
216 ATRIOVENTRICULAR BLOCK 70 0.0090
217 PURPURA 80 0.0090
218 BODY HEIGHT DECREASED 96 0.0090
219 HIATUS HERNIA 116 0.0089
220 CARDIAC VALVE DISEASE 51 0.0089
221 INCREASED TENDENCY TO BRUISE 82 0.0089
222 MELAENA 196 0.0089
223 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 45 0.0089
224 MUSCULAR WEAKNESS 1007 0.0089
225 ATRIAL FIBRILLATION 853 0.0088
226 URINE ODOUR ABNORMAL 51 0.0087
227 BLOOD TRIGLYCERIDES INCREASED 153 0.0087
228 LEFT VENTRICULAR DYSFUNCTION 58 0.0087
229 CORONARY ARTERY DISEASE 262 0.0086
230 DUODENAL ULCER 61 0.0086
231 ASCITES 254 0.0086
232 TOXIC EPIDERMAL NECROLYSIS 131 0.0086
233 VEIN DISORDER 43 0.0086
234 DYSURIA 316 0.0086
235 NEPHROPATHY 80 0.0086
236 SKIN FISSURES 167 0.0085
237 FLANK PAIN 80 0.0085
238 INTERNATIONAL NORMALISED RATIO INCREASED 243 0.0085
239 BENIGN PROSTATIC HYPERPLASIA 44 0.0085
240 SKIN ATROPHY 49 0.0085
241 LACRIMATION INCREASED 256 0.0085
242 GANGRENE 51 0.0085
243 ECZEMA 442 0.0084
244 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 438 0.0084
245 DERMATITIS EXFOLIATIVE 42 0.0084
246 DRUG-INDUCED LIVER INJURY 263 0.0084
247 SENSITIVITY TO WEATHER CHANGE 44 0.0084
248 RED BLOOD CELL COUNT DECREASED 239 0.0084
249 HAEMOGLOBIN DECREASED 856 0.0083
250 ORTHOSTATIC HYPOTENSION 145 0.0083
251 FLUID RETENTION 423 0.0083
252 EPISTAXIS 621 0.0083
253 MYASTHENIA GRAVIS 67 0.0083
254 COLITIS 314 0.0083
255 CHOLESTASIS 159 0.0083
256 SCIATICA 132 0.0083
257 BLOOD SODIUM DECREASED 156 0.0083
258 PERIPHERAL SWELLING 1275 0.0083
259 THERAPY NON-RESPONDER 371 0.0082
260 SCRATCH 87 0.0082
261 DIABETES MELLITUS INADEQUATE CONTROL 146 0.0082
262 MOTOR DYSFUNCTION 84 0.0082
263 HYPERLIPIDAEMIA 98 0.0082
264 NASAL CONGESTION 481 0.0082
265 HEPATITIS ACUTE 53 0.0081
266 MUSCLE SPASMS 1496 0.0081
267 PULMONARY OEDEMA 365 0.0081
268 BLOOD PRESSURE ABNORMAL 161 0.0081
269 BLOOD PRESSURE DECREASED 537 0.0081
270 SENSORY LOSS 65 0.0081
271 NOCTURIA 98 0.0081
272 INFUSION SITE EXTRAVASATION 50 0.0080
273 PULMONARY HYPERTENSION 167 0.0080
274 SYNCOPE 802 0.0080
275 CHROMATURIA 180 0.0080
276 DECREASED ACTIVITY 86 0.0080
277 OROPHARYNGEAL DISCOMFORT 72 0.0080
278 BLOOD PRESSURE INCREASED 1212 0.0079
279 ELECTROLYTE IMBALANCE 92 0.0079
280 MUSCULOSKELETAL DISCOMFORT 136 0.0079
281 HEART RATE ABNORMAL 44 0.0079
282 EYE INFECTION 89 0.0079
283 MUSCLE STRAIN 68 0.0079
284 POOR VENOUS ACCESS 81 0.0078
285 ASTHENOPIA 43 0.0078
286 HAEMOPTYSIS 218 0.0078
287 SKIN ULCER 202 0.0078
288 BRADYKINESIA 46 0.0078
289 BLOOD CREATININE INCREASED 506 0.0077
290 CARDIAC FLUTTER 50 0.0077
291 LOCALISED INFECTION 187 0.0077
292 BRONCHITIS 572 0.0077
293 CARDIOMEGALY 95 0.0077
294 CARDIAC FAILURE 620 0.0077
295 HYPOKINESIA 112 0.0077
296 SINUSITIS 789 0.0077
297 DYSPEPSIA 757 0.0077
298 COLITIS ULCERATIVE 343 0.0077
299 RENAL FAILURE CHRONIC 59 0.0077
300 HYPERCHOLESTEROLAEMIA 74 0.0077
301 UPPER RESPIRATORY TRACT INFECTION 354 0.0077
302 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 545 0.0077
303 SWELLING OF EYELID 48 0.0076
304 JOINT INJURY 163 0.0076
305 WEIGHT DECREASED 2120 0.0076
306 EOSINOPHILIA 133 0.0076
307 RESPIRATORY SYNCYTIAL VIRUS INFECTION 66 0.0076
308 FALL 2520 0.0076
309 HAEMATOCRIT DECREASED 150 0.0076
310 CHEST DISCOMFORT 774 0.0076
311 ANURIA 65 0.0075
312 ELECTROCARDIOGRAM ABNORMAL 59 0.0075
313 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 361 0.0075
314 TRANSAMINASES INCREASED 167 0.0075
315 ABNORMAL LOSS OF WEIGHT 51 0.0075
316 PULMONARY FIBROSIS 143 0.0074
317 BODY TEMPERATURE INCREASED 152 0.0074
318 HYPERKERATOSIS 41 0.0074
319 WHEEZING 439 0.0074
320 SPINAL OSTEOARTHRITIS 65 0.0074
321 HOT FLUSH 556 0.0074
322 SWOLLEN TONGUE 230 0.0074
323 OEDEMA 399 0.0073
324 HEMIPLEGIA 61 0.0073
325 POLYURIA 60 0.0073
326 LOWER RESPIRATORY TRACT INFECTION 333 0.0073
327 CATARACT 436 0.0073
328 PANCREATITIS ACUTE 164 0.0073
329 TRANSIENT ISCHAEMIC ATTACK 246 0.0073
330 HYPOTENSION 1460 0.0073
331 BLOOD ALKALINE PHOSPHATASE INCREASED 180 0.0072
332 DRUG INTOLERANCE 700 0.0072
333 BRADYCARDIA 383 0.0072
334 WOUND INFECTION 79 0.0072
335 RIB FRACTURE 148 0.0072
336 NASAL DRYNESS 45 0.0072
337 PRODUCT DOSE OMISSION IN ERROR 203 0.0072
338 ILLNESS 737 0.0071
339 CHEST PAIN 1320 0.0071
340 EAR PAIN 138 0.0071
341 TASTE DISORDER 144 0.0071
342 BLOOD POTASSIUM DECREASED 213 0.0071
343 BRAIN FOG 111 0.0071
344 LIVER FUNCTION TEST ABNORMAL 205 0.0070
345 LIPASE INCREASED 54 0.0070
346 ABDOMINAL DISCOMFORT 1182 0.0070
347 IRON DEFICIENCY ANAEMIA 65 0.0070
348 CARDIOGENIC SHOCK 101 0.0070
349 HYPOCALCAEMIA 133 0.0070
350 EYE DISCHARGE 73 0.0070
351 IMPAIRED QUALITY OF LIFE 101 0.0070
352 OEDEMA PERIPHERAL 854 0.0070
353 ASTHENIA 2628 0.0070
354 CARDIO-RESPIRATORY ARREST 292 0.0070
355 AUTOIMMUNE DISORDER 68 0.0070
356 DYSPNOEA 3940 0.0070
357 DRUG EFFECT LESS THAN EXPECTED 103 0.0069
358 PAIN IN EXTREMITY 2045 0.0069
359 GLYCOSYLATED HAEMOGLOBIN INCREASED 175 0.0069
360 SINUS BRADYCARDIA 67 0.0069
361 KIDNEY INFECTION 136 0.0069
362 PRODUCT ADMINISTRATION ERROR 140 0.0069
363 HAND FRACTURE 49 0.0069
364 MOVEMENT DISORDER 222 0.0069
365 CONSTIPATION 1507 0.0069
366 URINARY TRACT INFECTION 1178 0.0069
367 HYPOAESTHESIA ORAL 104 0.0069
368 ARTHRITIS 542 0.0069
369 DRY THROAT 70 0.0069
370 MALNUTRITION 77 0.0069
371 CYSTITIS 219 0.0069
372 OROPHARYNGEAL PAIN 635 0.0069
373 POLLAKIURIA 286 0.0069
374 CARDIOMYOPATHY 101 0.0068
375 NEURALGIA 166 0.0068
376 SNEEZING 153 0.0068
377 INFUSION RELATED REACTION 452 0.0068
378 HYPOXIA 240 0.0068
379 DECREASED APPETITE 1581 0.0068
380 TENDON RUPTURE 84 0.0068
381 MUSCULOSKELETAL CHEST PAIN 105 0.0068
382 HEART RATE INCREASED 670 0.0068
383 LIVER INJURY 166 0.0068
384 NIGHTMARE 234 0.0068
385 GASTRIC ULCER 128 0.0067
386 HEMIPARESIS 114 0.0067
387 PRODUCT USE COMPLAINT 106 0.0067
388 VENTRICULAR TACHYCARDIA 111 0.0067
389 DYSGEUSIA 499 0.0067
390 PETECHIAE 70 0.0067
391 HYPOGLYCAEMIA 325 0.0067
392 STENT PLACEMENT 54 0.0067
393 PRODUCT DOSE OMISSION ISSUE 1968 0.0067
394 BALANCE DISORDER 578 0.0067
395 FACIAL PARALYSIS 57 0.0067
396 HAEMOGLOBIN ABNORMAL 43 0.0067
397 HEART RATE IRREGULAR 151 0.0067
398 ACUTE RESPIRATORY FAILURE 128 0.0066
399 COVID-19 1167 0.0066
400 HYPOKALAEMIA 306 0.0066
401 CELLULITIS 334 0.0066
402 ARTHROPOD BITE 49 0.0066
403 INTENTIONAL DOSE OMISSION 188 0.0066
404 LIMB DISCOMFORT 204 0.0066
405 DIARRHOEA 4254 0.0066
406 AORTIC ANEURYSM 50 0.0066
407 DIVERTICULITIS 182 0.0066
408 INFLUENZA 732 0.0066
409 FAECES DISCOLOURED 142 0.0065
410 PAIN IN JAW 185 0.0065
411 NECK PAIN 364 0.0065
412 LOWER GASTROINTESTINAL HAEMORRHAGE 48 0.0065
413 GROIN PAIN 57 0.0065
414 HEAD INJURY 205 0.0065
415 FAECES SOFT 47 0.0065
416 BACK DISORDER 105 0.0065
417 PLATELET COUNT INCREASED 84 0.0064
418 CHILLS 755 0.0064
419 NEUROPATHY PERIPHERAL 612 0.0064
420 CHOLELITHIASIS 211 0.0064
421 RED BLOOD CELL SEDIMENTATION RATE INCREASED 71 0.0064
422 BLOOD CALCIUM DECREASED 72 0.0064
423 EATING DISORDER 136 0.0064
424 VERTIGO 389 0.0064
425 DYSARTHRIA 240 0.0064
426 RENAL DISORDER 297 0.0064
427 HERNIA 123 0.0064
428 PEMPHIGOID 48 0.0064
429 CARDIAC DISORDER 595 0.0064
430 PERICARDIAL EFFUSION 147 0.0064
431 ULCER HAEMORRHAGE 43 0.0063
432 DIZZINESS 3152 0.0063
433 FLATULENCE 358 0.0063
434 VENTRICULAR FIBRILLATION 70 0.0063
435 THYROID DISORDER 97 0.0063
436 COMA 299 0.0063
437 FACIAL PAIN 56 0.0063
438 ARTHRALGIA 2608 0.0063
439 IMPAIRED WORK ABILITY 134 0.0063
440 BLOOD TEST ABNORMAL 88 0.0063
441 RASH PAPULAR 140 0.0062
442 HYPERSOMNIA 179 0.0062
443 EAR DISCOMFORT 64 0.0062
444 PRURITUS 2393 0.0062
445 OESOPHAGITIS 68 0.0062
446 GAIT INABILITY 208 0.0062
447 SKIN SWELLING 54 0.0062
448 THERAPY PARTIAL RESPONDER 97 0.0062
449 PNEUMONIA 2007 0.0062
450 DIVERTICULUM 44 0.0062
451 NASOPHARYNGITIS 1141 0.0062
452 SLEEP APNOEA SYNDROME 118 0.0062
453 COVID-19 PNEUMONIA 73 0.0062
454 FATIGUE 4809 0.0062
455 HAEMATOMA 160 0.0062
456 GAIT DISTURBANCE 1180 0.0062
457 BACK PAIN 1431 0.0062
458 MYOCARDIAL INFARCTION 1073 0.0061
459 POST PROCEDURAL INFECTION 50 0.0061
460 CARPAL TUNNEL SYNDROME 86 0.0061
461 GRIP STRENGTH DECREASED 54 0.0061
462 BLOOD COUNT ABNORMAL 93 0.0061
463 JAUNDICE 165 0.0061
464 SINUS TACHYCARDIA 87 0.0061
465 BLINDNESS 249 0.0061
466 HAEMORRHOIDS 119 0.0061
467 HEPATITIS 156 0.0061
468 JOINT EFFUSION 42 0.0061
469 FOOD ALLERGY 47 0.0061
470 END STAGE RENAL DISEASE 111 0.0061
471 UROSEPSIS 56 0.0061
472 OCULAR HYPERAEMIA 288 0.0061
473 DIALYSIS 86 0.0061
474 FOOT DEFORMITY 67 0.0060
475 HEPATIC ENZYME INCREASED 412 0.0060
476 HYPERTRANSAMINASAEMIA 42 0.0060
477 EYE IRRITATION 346 0.0060
478 WHITE BLOOD CELL COUNT INCREASED 230 0.0060
479 PULMONARY CONGESTION 79 0.0060
480 PNEUMONIA BACTERIAL 55 0.0060
481 INFARCTION 41 0.0060
482 PRODUCT ADMINISTRATION INTERRUPTED 47 0.0060
483 ORAL PAIN 134 0.0060
484 GASTROENTERITIS VIRAL 108 0.0060
485 HEPATIC FUNCTION ABNORMAL 223 0.0060
486 DEHYDRATION 796 0.0060
487 CLOSTRIDIUM DIFFICILE COLITIS 63 0.0059
488 EAR INFECTION 158 0.0059
489 RENAL FAILURE 788 0.0059
490 AGEUSIA 148 0.0059
491 BLOOD CALCIUM INCREASED 52 0.0059
492 HYPERGLYCAEMIA 216 0.0059
493 CONTUSION 569 0.0059
494 ASPARTATE AMINOTRANSFERASE INCREASED 313 0.0059
495 GASTROOESOPHAGEAL REFLUX DISEASE 474 0.0059
496 SLUGGISHNESS 60 0.0059
497 LUNG DISORDER 288 0.0059
498 NEPHROLITHIASIS 269 0.0059
499 VISION BLURRED 805 0.0059
500 DYSSTASIA 171 0.0059
501 HEPATOCELLULAR INJURY 83 0.0058
502 EMPHYSEMA 59 0.0058
503 RENAL IMPAIRMENT 491 0.0058
504 CONFUSIONAL STATE 944 0.0058
505 POST PROCEDURAL COMPLICATION 112 0.0058
506 TRANSFUSION 61 0.0058
507 RENAL TUBULAR NECROSIS 57 0.0058
508 HYPOACUSIS 250 0.0058
509 HYPERTHYROIDISM 84 0.0058
510 C-REACTIVE PROTEIN INCREASED 211 0.0058
511 ALANINE AMINOTRANSFERASE INCREASED 356 0.0058
512 SEPSIS 646 0.0058
513 ACUTE KIDNEY INJURY 884 0.0058
514 INTERNAL HAEMORRHAGE 66 0.0058
515 EYE HAEMORRHAGE 77 0.0058
516 HEADACHE 3616 0.0058
517 CHRONIC KIDNEY DISEASE 438 0.0058
518 CEREBROVASCULAR ACCIDENT 976 0.0058
519 ACIDOSIS 44 0.0058
520 TENDONITIS 89 0.0057
521 DYSPHONIA 336 0.0057
522 APHONIA 80 0.0057
523 PULMONARY ARTERIAL HYPERTENSION 83 0.0057
524 CARDIAC FAILURE CONGESTIVE 460 0.0057
525 HIP FRACTURE 184 0.0057
526 RASH PRURITIC 309 0.0057
527 CARDIAC OPERATION 49 0.0057
528 SUBARACHNOID HAEMORRHAGE 58 0.0057
529 URINARY RETENTION 190 0.0057
530 HYPOPHOSPHATAEMIA 42 0.0057
531 JOINT STIFFNESS 149 0.0057
532 ABDOMINAL PAIN UPPER 1169 0.0057
533 RETCHING 121 0.0057
534 CEREBRAL INFARCTION 138 0.0056
535 ANAEMIA 1077 0.0056
536 FEELING COLD 157 0.0056
537 HALLUCINATION, VISUAL 119 0.0056
538 GASTROINTESTINAL HAEMORRHAGE 471 0.0056
539 GASTRITIS 148 0.0056
540 INSOMNIA 1497 0.0056
541 EYE SWELLING 209 0.0056
542 URINE OUTPUT DECREASED 49 0.0056
543 DYSPHAGIA 529 0.0056
544 FLUSHING 565 0.0056
545 RESPIRATORY DISORDER 166 0.0055
546 TENDON PAIN 42 0.0055
547 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 999 0.0055
548 MUSCLE SPASTICITY 68 0.0055
549 POOR QUALITY SLEEP 119 0.0055
550 BACK INJURY 60 0.0055
551 EYE PRURITUS 185 0.0055
552 PULMONARY MASS 82 0.0055
553 RASH MACULAR 192 0.0055
554 PLATELET COUNT DECREASED 585 0.0055
555 MALAISE 2403 0.0055
556 PROTEINURIA 104 0.0055
557 PERIPHERAL COLDNESS 75 0.0055
558 COORDINATION ABNORMAL 76 0.0054
559 ANAL INCONTINENCE 49 0.0054
560 SKIN INFECTION 61 0.0054
561 SLEEP DISORDER 383 0.0054
562 PLEURAL EFFUSION 330 0.0054
563 WRIST FRACTURE 65 0.0054
564 HYPERTENSION 1148 0.0054
565 ASTHMA 612 0.0054
566 HEPATIC CYTOLYSIS 69 0.0054
567 HEPATIC FAILURE 163 0.0054
568 OBESITY 86 0.0054
569 PALPITATIONS 630 0.0054
570 DRUG LEVEL INCREASED 89 0.0054
571 RASH ERYTHEMATOUS 257 0.0054
572 ERUCTATION 104 0.0054
573 LIGAMENT SPRAIN 53 0.0054
574 DIABETES MELLITUS 408 0.0053
575 MICTURITION URGENCY 61 0.0053
576 DEMENTIA 149 0.0053
577 JOINT SWELLING 643 0.0053
578 HYPOPHAGIA 136 0.0053
579 NERVE INJURY 59 0.0053
580 HYPERTENSIVE CRISIS 59 0.0053
581 ABDOMINAL DISTENSION 553 0.0053
582 CIRCULATORY COLLAPSE 90 0.0053
583 COAGULOPATHY 88 0.0053
584 ABDOMINAL PAIN 1224 0.0053
585 TOOTH FRACTURE 58 0.0053
586 DEVICE OCCLUSION 74 0.0053
587 SOMNOLENCE 1057 0.0052
588 PULMONARY THROMBOSIS 57 0.0052
589 SKIN EXFOLIATION 441 0.0052
590 ULCER 83 0.0052
591 HYPOTONIA 52 0.0052
592 ACCIDENTAL OVERDOSE 190 0.0052
593 THERAPEUTIC RESPONSE SHORTENED 172 0.0052
594 LABORATORY TEST ABNORMAL 153 0.0052
595 MUSCLE RIGIDITY 62 0.0052
596 DRY SKIN 692 0.0052
597 SCAB 59 0.0052
598 LIVER FUNCTION TEST INCREASED 111 0.0052
599 HYPONATRAEMIA 291 0.0052
600 TOOTH INFECTION 68 0.0052
601 DECUBITUS ULCER 42 0.0051
602 BLOOD BILIRUBIN INCREASED 139 0.0051
603 INTERSTITIAL LUNG DISEASE 249 0.0051
604 DRUG ERUPTION 91 0.0051
605 URINARY INCONTINENCE 152 0.0051
606 FEEDING DISORDER 104 0.0051
607 VITAMIN D DEFICIENCY 50 0.0051
608 ANOREXIA 66 0.0051
609 DRY EYE 255 0.0051
610 WHITE BLOOD CELL COUNT DECREASED 553 0.0051
611 MOBILITY DECREASED 366 0.0051
612 SKIN DISCOLOURATION 234 0.0051
613 DERMATITIS ATOPIC 268 0.0051
614 TOOTH DISORDER 113 0.0051
615 DISORIENTATION 201 0.0051
616 MUSCLE INJURY 42 0.0051
617 INTENTIONAL PRODUCT USE ISSUE 444 0.0051
618 INFLUENZA LIKE ILLNESS 417 0.0051
619 BASAL CELL CARCINOMA 79 0.0051
620 ERECTILE DYSFUNCTION 130 0.0051
621 ERYTHEMA MULTIFORME 47 0.0050
622 INTERVERTEBRAL DISC PROTRUSION 110 0.0050
623 PYREXIA 1741 0.0050
624 TACHYCARDIA 447 0.0050
625 LIVER DISORDER 223 0.0050
626 FOOT FRACTURE 95 0.0050
627 THROMBOSIS 403 0.0050
628 WOUND 140 0.0050
629 PHARYNGEAL SWELLING 49 0.0050
630 LACTIC ACIDOSIS 162 0.0050
631 SKIN LESION 137 0.0050
632 SYNOVITIS 90 0.0050
633 BLISTER 280 0.0050
634 NEUTROPHIL COUNT INCREASED 51 0.0050
635 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 44 0.0050
636 INTERVERTEBRAL DISC DEGENERATION 46 0.0050
637 VIRAL INFECTION 165 0.0050
638 CHOLECYSTITIS 59 0.0049
639 SPINAL OPERATION 61 0.0049
640 THERAPY INTERRUPTED 353 0.0049
641 NAUSEA 3899 0.0049
642 MUSCULOSKELETAL STIFFNESS 431 0.0049
643 VITAMIN D DECREASED 42 0.0049
644 PSEUDOMONAS INFECTION 42 0.0049
645 HEPATIC CIRRHOSIS 92 0.0049
646 TENDERNESS 51 0.0049
647 DRY MOUTH 397 0.0049
648 MEMORY IMPAIRMENT 672 0.0049
649 CONTRAINDICATED PRODUCT ADMINISTERED 148 0.0049
650 ATELECTASIS 47 0.0049
651 PAIN 2978 0.0048
652 PHOTOSENSITIVITY REACTION 80 0.0048
653 HERPES ZOSTER 278 0.0048
654 BLOOD GLUCOSE ABNORMAL 89 0.0048
655 BLOOD LACTATE DEHYDROGENASE INCREASED 76 0.0048
656 RESTLESS LEGS SYNDROME 87 0.0048
657 ANKLE FRACTURE 74 0.0048
658 MUSCULOSKELETAL PAIN 250 0.0048
659 COLON CANCER 71 0.0048
660 PRESCRIBED UNDERDOSE 95 0.0048
661 POLYNEUROPATHY 57 0.0048
662 NODULE 62 0.0047
663 SUBDURAL HAEMATOMA 68 0.0047
664 ROTATOR CUFF SYNDROME 61 0.0047
665 LOSS OF CONSCIOUSNESS 607 0.0047
666 CANDIDA INFECTION 80 0.0047
667 SKIN CANCER 102 0.0047
668 AMNESIA 308 0.0047
669 INCONTINENCE 50 0.0047
670 DEPRESSED MOOD 250 0.0047
671 LETHARGY 272 0.0047
672 ISCHAEMIC STROKE 84 0.0047
673 APHASIA 142 0.0047
674 SUPRAVENTRICULAR TACHYCARDIA 45 0.0047
675 ELECTROCARDIOGRAM QT PROLONGED 169 0.0047
676 SPINAL FRACTURE 94 0.0047
677 HEPATOMEGALY 46 0.0047
678 GASTROINTESTINAL DISORDER 419 0.0047
679 TOXIC SKIN ERUPTION 47 0.0047
680 TEMPERATURE INTOLERANCE 48 0.0046
681 ARTHROPATHY 258 0.0046
682 POST PROCEDURAL HAEMORRHAGE 54 0.0046
683 HYPOTHYROIDISM 148 0.0046
684 EXPOSURE VIA SKIN CONTACT 120 0.0046
685 MUSCLE TIGHTNESS 75 0.0046
686 MUSCULOSKELETAL DISORDER 88 0.0046
687 FUNGAL INFECTION 154 0.0046
688 SPINAL PAIN 54 0.0046
689 OSTEOARTHRITIS 195 0.0046
690 ERYTHEMA 945 0.0046
691 HYPOAESTHESIA 687 0.0046
692 GASTROINTESTINAL INFECTION 41 0.0046
693 AFFECT LABILITY 44 0.0046
694 RETINAL DETACHMENT 42 0.0046
695 ORAL HERPES 89 0.0046
696 PARAESTHESIA 716 0.0045
697 NERVE COMPRESSION 42 0.0045
698 JOINT RANGE OF MOTION DECREASED 61 0.0045
699 SARS-COV-2 TEST POSITIVE 60 0.0045
700 DELIRIUM 157 0.0045
701 MULTI-ORGAN FAILURE 78 0.0045
702 ARRHYTHMIA 213 0.0045
703 HYPERHIDROSIS 579 0.0045
704 DIARRHOEA HAEMORRHAGIC 42 0.0045
705 CEREBRAL HAEMORRHAGE 160 0.0045
706 MASS 62 0.0044
707 GASTRIC DISORDER 152 0.0044
708 OSTEOPOROSIS 182 0.0044
709 DRUG TOXICITY 60 0.0044
710 EYE INFLAMMATION 42 0.0044
711 FIBROMYALGIA 107 0.0044
712 INJECTION SITE IRRITATION 56 0.0044
713 SYSTEMIC LUPUS ERYTHEMATOSUS 156 0.0044
714 FEELING ABNORMAL 1053 0.0044
715 SPEECH DISORDER 230 0.0044
716 BACTERAEMIA 52 0.0044
717 INFLAMMATION 226 0.0044
718 NIGHT SWEATS 141 0.0044
719 UPPER LIMB FRACTURE 87 0.0044
720 RASH 1902 0.0044
721 PHARYNGITIS 54 0.0043
722 PNEUMONIA ASPIRATION 108 0.0043
723 LOWER LIMB FRACTURE 83 0.0043
724 VOMITING 2030 0.0043
725 GASTROENTERITIS 63 0.0043
726 PARKINSONISM 42 0.0043
727 FEELING HOT 263 0.0043
728 BACTERIAL INFECTION 80 0.0043
729 DIABETIC KETOACIDOSIS 103 0.0043
730 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 44 0.0043
731 BURNING SENSATION 300 0.0043
732 NEOPLASM 49 0.0043
733 GALLBLADDER DISORDER 76 0.0043
734 SKIN DISORDER 142 0.0043
735 LEUKOCYTOSIS 77 0.0043
736 SWELLING 398 0.0042
737 RESPIRATORY FAILURE 309 0.0042
738 CONDITION AGGRAVATED 1287 0.0042
739 WEIGHT INCREASED 945 0.0042
740 RHEUMATOID ARTHRITIS 479 0.0042
741 SALIVARY HYPERSECRETION 42 0.0042
742 TOOTHACHE 76 0.0042
743 THIRST 75 0.0042
744 LYMPHOCYTE COUNT DECREASED 74 0.0042
745 PRODUCT USE IN UNAPPROVED INDICATION 1037 0.0042
746 BONE PAIN 245 0.0042
747 MIGRAINE 397 0.0042
748 HYPOTHERMIA 42 0.0041
749 MULTIPLE ORGAN DYSFUNCTION SYNDROME 117 0.0041
750 BLOOD GLUCOSE INCREASED 778 0.0041
751 CLOSTRIDIUM DIFFICILE INFECTION 90 0.0041
752 BURSITIS 50 0.0041
753 ACUTE HEPATIC FAILURE 56 0.0041
754 INFECTION 589 0.0041
755 PROSTATIC SPECIFIC ANTIGEN INCREASED 56 0.0041
756 PRODUCT TASTE ABNORMAL 55 0.0041
757 BLOOD GLUCOSE DECREASED 195 0.0041
758 HYPERCALCAEMIA 50 0.0040
759 VENTRICULAR EXTRASYSTOLES 42 0.0040
760 STAPHYLOCOCCAL INFECTION 133 0.0040
761 ASPIRATION 44 0.0040
762 EYE DISORDER 132 0.0040
763 HAEMORRHAGE INTRACRANIAL 60 0.0040
764 DEEP VEIN THROMBOSIS 260 0.0040
765 TREATMENT NONCOMPLIANCE 218 0.0040
766 PULMONARY EMBOLISM 378 0.0040
767 FACE OEDEMA 67 0.0040
768 CHOKING 77 0.0039
769 DEVICE FAILURE 60 0.0039
770 STOMATITIS 239 0.0039
771 ABDOMINAL PAIN LOWER 99 0.0039
772 HALLUCINATION 294 0.0039
773 DEAFNESS 102 0.0039
774 DERMATITIS ALLERGIC 49 0.0039
775 GLAUCOMA 75 0.0039
776 DEVICE USE ISSUE 68 0.0039
777 CONJUNCTIVITIS 72 0.0039
778 UNRESPONSIVE TO STIMULI 100 0.0039
779 CYST 48 0.0039
780 BRONCHOSPASM 55 0.0039
781 ACCIDENT 46 0.0038
782 ANGIOEDEMA 170 0.0038
783 TREMOR 637 0.0038
784 FEELING JITTERY 73 0.0038
785 IMMUNODEFICIENCY 57 0.0038
786 PANCREATITIS 202 0.0038
787 PALLOR 104 0.0038
788 SMALL INTESTINAL OBSTRUCTION 47 0.0038
789 OSTEOMYELITIS 69 0.0038
790 PRODUCT DOSE OMISSION 247 0.0038
791 MENTAL STATUS CHANGES 104 0.0037
792 GINGIVAL BLEEDING 51 0.0037
793 COGNITIVE DISORDER 174 0.0037
794 CARDIAC ARREST 307 0.0037
795 PNEUMONITIS 101 0.0037
796 KNEE ARTHROPLASTY 78 0.0037
797 THROMBOCYTOPENIA 414 0.0037
798 SEPTIC SHOCK 161 0.0037
799 TOOTH EXTRACTION 46 0.0037
800 COLD SWEAT 65 0.0037
801 HEPATOTOXICITY 82 0.0037
802 SCAR 63 0.0037
803 SENSORY DISTURBANCE 59 0.0037
804 DERMATITIS 77 0.0037
805 HYPERSENSITIVITY 682 0.0037
806 PRODUCT DISPENSING ERROR 80 0.0037
807 DELUSION 57 0.0037
808 GENERAL PHYSICAL HEALTH DETERIORATION 424 0.0037
809 HOSPITALISATION 563 0.0037
810 ADVERSE DRUG REACTION 329 0.0037
811 ANOSMIA 53 0.0037
812 MALIGNANT MELANOMA 49 0.0037
813 DEPRESSION 827 0.0036
814 LIP SWELLING 121 0.0036
815 BLINDNESS UNILATERAL 51 0.0036
816 INTESTINAL OBSTRUCTION 135 0.0036
817 BEDRIDDEN 47 0.0036
818 PSORIATIC ARTHROPATHY 145 0.0036
819 THERAPEUTIC RESPONSE DECREASED 216 0.0036
820 CYANOSIS 56 0.0036
821 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 91 0.0035
822 VISUAL IMPAIRMENT 438 0.0035
823 METABOLIC ACIDOSIS 113 0.0035
824 PNEUMOTHORAX 56 0.0035
825 PRURITUS GENERALISED 76 0.0035
826 DISTURBANCE IN ATTENTION 189 0.0035
827 PARALYSIS 50 0.0035
828 PRODUCT SUBSTITUTION ISSUE 201 0.0035
829 NERVOUSNESS 182 0.0035
830 PLASMA CELL MYELOMA 135 0.0035
831 TACHYPNOEA 47 0.0035
832 MENTAL DISORDER 149 0.0034
833 DRUG INEFFECTIVE 4490 0.0034
834 MEDICATION ERROR 188 0.0034
835 IMPAIRED GASTRIC EMPTYING 46 0.0034
836 COMPLICATION ASSOCIATED WITH DEVICE 49 0.0034
837 DYSKINESIA 137 0.0034
838 PRODUCT PHYSICAL ISSUE 68 0.0034
839 RESPIRATORY DISTRESS 93 0.0034
840 RENAL INJURY 100 0.0034
841 SWELLING FACE 219 0.0034
842 SHOCK 77 0.0033
843 OFF LABEL USE 2922 0.0033
844 AGRANULOCYTOSIS 62 0.0033
845 THROAT TIGHTNESS 90 0.0033
846 URTICARIA 556 0.0033
847 PRODUCT PRESCRIBING ERROR 79 0.0033
848 FLUID OVERLOAD 48 0.0033
849 ANXIETY 931 0.0033
850 DISCOMFORT 199 0.0033
851 DISEASE PROGRESSION 385 0.0033
852 HAEMORRHAGE 340 0.0032
853 MULTIPLE SCLEROSIS 155 0.0032
854 ABASIA 80 0.0032
855 RASH MACULO-PAPULAR 72 0.0032
856 DEPRESSED LEVEL OF CONSCIOUSNESS 128 0.0032
857 LYMPHOMA 50 0.0032
858 PANIC ATTACK 117 0.0032
859 PRODUCT USE ISSUE 602 0.0032
860 UNEVALUABLE EVENT 241 0.0032
861 PRESCRIBED OVERDOSE 61 0.0031
862 ABNORMAL DREAMS 87 0.0031
863 HAIR TEXTURE ABNORMAL 42 0.0031
864 ENCEPHALOPATHY 77 0.0031
865 BONE DISORDER 57 0.0031
866 SKIN REACTION 44 0.0031
867 PANCYTOPENIA 174 0.0031
868 LYMPHADENOPATHY 110 0.0031
869 INTENTIONAL PRODUCT MISUSE 272 0.0031
870 PAIN OF SKIN 83 0.0031
871 INJECTION SITE RASH 94 0.0031
872 ABSCESS 48 0.0030
873 THINKING ABNORMAL 56 0.0030
874 ROAD TRAFFIC ACCIDENT 125 0.0030
875 IMPAIRED HEALING 98 0.0030
876 DISSEMINATED INTRAVASCULAR COAGULATION 42 0.0030
877 ALOPECIA 584 0.0030
878 FEMUR FRACTURE 92 0.0030
879 MENTAL IMPAIRMENT 72 0.0030
880 LYMPHOPENIA 42 0.0030
881 ECONOMIC PROBLEM 45 0.0030
882 MUSCLE TWITCHING 68 0.0029
883 APATHY 43 0.0029
884 THERAPEUTIC PRODUCT EFFECT DECREASED 132 0.0029
885 PRODUCT AVAILABILITY ISSUE 67 0.0029
886 HIP ARTHROPLASTY 45 0.0029
887 FEBRILE NEUTROPENIA 194 0.0029
888 AGITATION 213 0.0029
889 DISEASE RECURRENCE 137 0.0029
890 INCREASED APPETITE 55 0.0029
891 ANAPHYLACTIC REACTION 159 0.0029
892 NEEDLE ISSUE 83 0.0028
893 SURGERY 167 0.0028
894 HALLUCINATION, AUDITORY 45 0.0028
895 VISUAL ACUITY REDUCED 94 0.0028
896 LUNG NEOPLASM MALIGNANT 116 0.0028
897 RASH GENERALISED 73 0.0028
898 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 48 0.0028
899 DEVICE RELATED INFECTION 43 0.0028
900 NEOPLASM PROGRESSION 97 0.0028
901 ACTIVITIES OF DAILY LIVING IMPAIRED 55 0.0028
902 INCORRECT DOSE ADMINISTERED 627 0.0027
903 PRODUCT PRESCRIBING ISSUE 59 0.0027
904 NEOPLASM MALIGNANT 179 0.0027
905 RESTLESSNESS 98 0.0027
906 SEIZURE 309 0.0027
907 INJECTION SITE PAIN 809 0.0026
908 GLOSSODYNIA 59 0.0026
909 PSORIASIS 336 0.0026
910 DEATH 2208 0.0026
911 NEUTROPHIL COUNT DECREASED 104 0.0025
912 ILL-DEFINED DISORDER 155 0.0025
913 INJECTION SITE SWELLING 195 0.0025
914 MOUTH ULCERATION 53 0.0025
915 PERICARDITIS 42 0.0025
916 INJECTION SITE PRURITUS 166 0.0025
917 DEVICE DISLOCATION 107 0.0025
918 LEUKOPENIA 123 0.0025
919 IRRITABLE BOWEL SYNDROME 52 0.0024
920 THERAPY CESSATION 123 0.0024
921 METASTASES TO LIVER 42 0.0024
922 COMPLETED SUICIDE 195 0.0023
923 INJECTION SITE MASS 86 0.0023
924 CARDIOVASCULAR DISORDER 59 0.0023
925 ABNORMAL BEHAVIOUR 92 0.0023
926 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 469 0.0023
927 MOOD ALTERED 63 0.0023
928 IRRITABILITY 138 0.0023
929 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 53 0.0023
930 BONE DENSITY DECREASED 70 0.0022
931 INJECTION SITE BRUISING 177 0.0022
932 NERVOUS SYSTEM DISORDER 69 0.0022
933 MULTIPLE SCLEROSIS RELAPSE 151 0.0022
934 DISABILITY 43 0.0022
935 EMOTIONAL DISORDER 67 0.0022
936 ANHEDONIA 57 0.0022
937 PSYCHOTIC DISORDER 64 0.0022
938 NEUTROPENIA 289 0.0021
939 AGGRESSION 106 0.0021
940 INJECTION SITE ERYTHEMA 261 0.0021
941 STEVENS-JOHNSON SYNDROME 46 0.0021
942 ANAPHYLACTIC SHOCK 53 0.0021
943 ADVERSE EVENT 188 0.0020
944 RESPIRATORY ARREST 56 0.0020
945 THERAPEUTIC RESPONSE UNEXPECTED 90 0.0020
946 INJECTION SITE URTICARIA 48 0.0020
947 CRYING 71 0.0020
948 SEDATION 51 0.0019
949 EPILEPSY 57 0.0019
950 SUICIDE ATTEMPT 112 0.0018
951 EXTRA DOSE ADMINISTERED 74 0.0018
952 CONVULSION 103 0.0018
953 FEAR 48 0.0018
954 INJURY 124 0.0018
955 INTENTIONAL OVERDOSE 112 0.0017
956 MOOD SWINGS 55 0.0017
957 ANGER 58 0.0017
958 TOXICITY TO VARIOUS AGENTS 288 0.0017
959 DEVICE USE ERROR 59 0.0017
960 DEVICE ISSUE 152 0.0017
961 DEVICE LEAKAGE 72 0.0017
962 SUICIDAL IDEATION 151 0.0016
963 MALIGNANT NEOPLASM PROGRESSION 168 0.0016
964 DRUG EFFECT DECREASED 87 0.0016
965 ACCIDENTAL EXPOSURE TO PRODUCT 164 0.0016
966 DEVICE MALFUNCTION 110 0.0016
967 OVERDOSE 336 0.0016
968 SKIN BURNING SENSATION 108 0.0015
969 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 104 0.0015
970 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 80 0.0015
971 UNDERDOSE 106 0.0015
972 ACNE 110 0.0014
973 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 67 0.0014
974 DRUG EFFECT INCOMPLETE 52 0.0014
975 SKIN IRRITATION 65 0.0014
976 WRONG TECHNIQUE IN DRUG USAGE PROCESS 50 0.0014
977 EMOTIONAL DISTRESS 163 0.0013
978 GYNAECOMASTIA 41 0.0013
979 INJECTION SITE HAEMORRHAGE 104 0.0013
980 DRUG DOSE OMISSION 213 0.0013
981 INJECTION SITE REACTION 81 0.0012
982 WITHDRAWAL SYNDROME 49 0.0012
983 VAGINAL HAEMORRHAGE 49 0.0011
984 TREATMENT FAILURE 92 0.0011
985 PROSTATE CANCER 86 0.0011
986 NO ADVERSE EVENT 188 0.0010
987 PRODUCT STORAGE ERROR 84 0.0010
988 PRODUCT QUALITY ISSUE 125 0.0009
989 BREAST CANCER 84 0.0009
990 DEVICE DIFFICULT TO USE 57 0.0009
991 DRUG DEPENDENCE 127 0.0008
992 BLADDER CANCER 45 0.0008
993 DRUG WITHDRAWAL SYNDROME 46 0.0005